Related terms for "acute toxicity testing ": toxicity testing applications
Tumor markers found in blood, urine and body tissues can be used in diagnosing and treating cancer. Each tumor marker is indicative of a particular disease and thus can be used for the screening, monitoring and diagnosis of specific tumor types. In addition to being used in prognosis, these molecular markers help to predict the response, resistance and toxicity to therapy. For example, BCR-ABL gene sequence detection is used to diagnose chronic myelogenous leukemia and acute lymphatic leukemia.
By Aurora Biomed Inc. based in Vancouver, BRITISH COLUMBIA (CANADA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you